Novel decision-theoretic and risk-stratification metrics of predictive performance: Application to deciding who should undergo genetic testing

Hormuzd A. Katki

Currently, women are referred for BRCA1/2 mutation-testing only if their family-history of breast/ovarian cancer implies that their risk of carrying a mutation exceeds 10\%. Howeve…